Project Grant HT94252410190
Award Date
4/1/24
Completion Date
3/31/28
Dollars Obligated
$1.9M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Albany, NY 12222, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency has awarded a $1,179,730 Project Grant to The Research Foundation for the State University of New York (RF-SUNY) at the University at Albany. The grant, under the Military Medical Research and Development program (CFDA 12.420), will fund research to identify new biological and therapeutic targets for myotonic dystrophy type 1, a genetic disorder affecting muscle function. The four-year grant, which began on April 1, 2024, will support basic,...
Under a $1,525,000 Project Grant awarded by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development), the University of Florida's Division of Sponsored Research will conduct research to "UNDERSTANDING AND TARGETING COMMON MECHANISMS OF MYOTONIC DYSTROPHY TYPES 1AND 2 USING NOVEL REPEAT EXPANSION MOUSE MODELS." This 4-year research project, commencing on Sep 1, 2023, will advance the understanding and treatment of myotonic dystrophy, a genetic disorder that...
This $1,525,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports foundational studies at the University of Florida to understand the phenotypic, region-specific, and cell-specific dysregulation in the central nervous system of individuals with myotonic dystrophy. The 4-year award, effective May 15, 2024, will enable the university to conduct innovative research to advance the understanding of this neurological...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $431,750.00 to the University of Houston System to conduct research on the role of H19X noncoding RNAs in the pathogenesis of myotonic dystrophy type I. The performance period for this research project runs from December 1, 2024 to November 30, 2026. The Military Medical Research and Development program supports advanced biomedical research...
The University of Florida (UF) received a $1,524,836 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on understanding and targeting common mechanisms of myotonic dystrophy types 1 and 2 using novel repeat expansion mouse models. The grant, which began on September 1, 2023 and will continue through August 31, 2027, supports UF's cutting-edge biomedical research efforts to transform healthcare for Service...
This $998,436 Project Grant was awarded on July 1, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Research Foundation for the State University of New York (RF SUNY) to study the molecular mechanisms and therapeutic potential of heparan sulfate proteoglycans in remyelination. This 3-year research project aims to transform health care for Service Members and the American public through innovative and...
This $563,484.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Duke University to regulate skeletal muscle fibrosis in Duchenne muscular dystrophy. The two-year award, effective June 1, 2024 through May 31, 2026, will enable Duke University's research team to advance understanding and potential treatments for this debilitating neuromuscular disorder affecting military service members and...
This federal Project Grant award of $673,448.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award was granted to The Research Foundation For The State University Of New York (RF SUNY) to conduct research on the "MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE...
The Department of the Army Medical Command awarded a $1,463,982 Project Grant to The Research Foundation for the State University of New York (RF SUNY) under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year research project titled "Defining the ABI1-Mediated Resistance to Enzalutamide" to investigate new treatments for military health priorities. The Research Foundation for the State University of New York, which serves as the fiscal...
The federal Project Grant award of $405,341.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports research conducted by the Children's Research Institute in Washington, DC to develop innovative pharmacological approaches for the treatment of Duchenne muscular dystrophy (DMD). The institute will leverage its expertise in areas like genetics, neuroscience, and translational medicine to explore novel therapeutic...